The content on this page is designed for . Check courses designed for Canada (EN)

This course has expired. View available courses.

Using Clinical Data to Combat Influenza in Older Adults

DURATION

PROFESSION

# OF CREDITS

ACCREDITATION

EXPIRY DATE

Influenza virus infection causes a wide spectrum of illness and presents an ongoing disease burden in Canada during the fall and winter months. Risk groups for influenza-related complications or hospitalization include older adults (≥ 65 years old), young children, pregnant persons, and individuals with certain chronic health conditions. Older adults represent the majority of hospitalizations, ICU admissions and deaths from influenza infection annually in Canada. Vaccination against influenza is crucial for older adults as it helps bolster their immune response, and reduces the likelihood of severe illness, hospitalization, morbidity and mortality. As such, adults 65 years of age and older are prioritized to receive influenza vaccines because of the increased risks of severe disease in this population. Inactivated high-dose, adjuvanted or recombinant influenza vaccines are recommended, when available, over other influenza vaccines for adults 65 years of age and older. This program will provide participants with key information about the three vaccines indicated for older adults in Canada, including an analysis of the data used to support the preferential recommendation for these vaccines. The goal is to inform discussions on how to optimize influenza protection among older adults in Canada.


This program has received an educational grant or in-kind support from Sanofi.

Cost of course:  
Free
# of credits:
Duration:

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.

Using Clinical Data to Combat Influenza in Older Adults

Duration

Profession

# of credits

Learning Objectives

ACF Learning Objectives

ACCREDITATION

Unavailable

Learning Category

General

Topic

Price

Expiry Date

Region/Language

Course Description

Influenza virus infection causes a wide spectrum of illness and presents an ongoing disease burden in Canada during the fall and winter months. Risk groups for influenza-related complications or hospitalization include older adults (≥ 65 years old), young children, pregnant persons, and individuals with certain chronic health conditions. Older adults represent the majority of hospitalizations, ICU admissions and deaths from influenza infection annually in Canada. Vaccination against influenza is crucial for older adults as it helps bolster their immune response, and reduces the likelihood of severe illness, hospitalization, morbidity and mortality. As such, adults 65 years of age and older are prioritized to receive influenza vaccines because of the increased risks of severe disease in this population. Inactivated high-dose, adjuvanted or recombinant influenza vaccines are recommended, when available, over other influenza vaccines for adults 65 years of age and older. This program will provide participants with key information about the three vaccines indicated for older adults in Canada, including an analysis of the data used to support the preferential recommendation for these vaccines. The goal is to inform discussions on how to optimize influenza protection among older adults in Canada.


This program has received an educational grant or in-kind support from Sanofi.

Faculty

ACF Faculty

Accreditation

Unaccredited